mitoxantrone has been researched along with Cancer of Paranasal Sinus in 1 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ma, HH | 1 |
| Qian, LT | 1 |
| Pan, HF | 1 |
| Yang, L | 1 |
| Zhang, HY | 1 |
| Wang, ZH | 1 |
| Ma, J | 1 |
| Zhao, YF | 1 |
| Gao, J | 1 |
| Wu, AD | 1 |
1 trial available for mitoxantrone and Cancer of Paranasal Sinus
| Article | Year |
|---|---|
Treatment outcome of radiotherapy alone versus radiochemotherapy in early stage nasal natural killer/T-cell lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Ad | 2010 |